(DEN-ih-LOO-kin DIF-tih-tox) A substance used to treat cutaneous T-cell lymphoma when other treatments have not worked. It is also being studied in the treatment of chronic lymphocytic leukemia that has not responded to treatment. It belongs to the family of drugs called biological therapy agents. Also called Ontak.
- Browse Related Terms: 18F-EF5, Amplimexon, beclomethasone, BG00001, CpG 7909, denileukin diftitox, hydroxychloroquine, imexon, iodine I 131 tositumomab, methoxsalen, mitoxantrone, Novantrone, Ontak, PF-3512676, ProMune, QS21, Virulizin, visilizumab